Terlipressin use in hepatorenal syndrome-acute kidney injury in cirrhosis. Author's reply

doi:10.1007/s00134-024-07720-0

. 2025 Jan;51(1):215-216.

doi: 10.1007/s00134-024-07720-0. Epub 2024 Nov 21.

Terlipressin use in hepatorenal syndrome-acute kidney injury in cirrhosis. Author's reply

Mitra K Nadim¹, Lui G Forni^{2

3}, Marlies Ostermann⁴; ADQI 29/ICA panel

Affiliations

¹ Division of Nephrology and Hypertension, Keck School of Medicine, University of Southern California, Los Angeles, USA.
² Critical Care Unit, Royal Surrey Hospital Foundation Trust, Guildford, UK.
³ School of Medicine, Kate Granger Building, University of Surrey, Guildford, UK.
⁴ Department of Intensive Care, King's College London, Guy's and St Thomas' Hospital, London, UK. Marlies.Ostermann@gstt.nhs.uk.

PMID: 39570402
DOI: 10.1007/s00134-024-07720-0

Terlipressin use in hepatorenal syndrome-acute kidney injury in cirrhosis. Author's reply

Mitra K Nadim et al. Intensive Care Med. 2025 Jan.

. 2025 Jan;51(1):215-216.

doi: 10.1007/s00134-024-07720-0. Epub 2024 Nov 21.

Authors

Mitra K Nadim¹, Lui G Forni^{2

3}, Marlies Ostermann⁴; ADQI 29/ICA panel

Affiliations

¹ Division of Nephrology and Hypertension, Keck School of Medicine, University of Southern California, Los Angeles, USA.
² Critical Care Unit, Royal Surrey Hospital Foundation Trust, Guildford, UK.
³ School of Medicine, Kate Granger Building, University of Surrey, Guildford, UK.
⁴ Department of Intensive Care, King's College London, Guy's and St Thomas' Hospital, London, UK. Marlies.Ostermann@gstt.nhs.uk.

PMID: 39570402
DOI: 10.1007/s00134-024-07720-0

No abstract available

PubMed Disclaimer

Cited by

Terlipressin use in hepatorenal syndrome-acute kidney injury in cirrhosis.
Wong F, Pappas SC. Wong F, et al. Intensive Care Med. 2025 Jan;51(1):213-214. doi: 10.1007/s00134-024-07681-4. Epub 2024 Oct 23. Intensive Care Med. 2025. PMID: 39441357 No abstract available.

References

1. Wong F, Pappas SC (2024) Terlipressin use in hepatorenal syndrome - acute kidney injury in cirrhosis. Intens Care Med. https://doi.org/10.1007/s00134-024-07681-4 - DOI
1. Nadim MK, Forni LG, Ostermann M (2024) ADQI / ICA Expert Panel. Hepatorenal syndrome in the intensive care unit. Intens Care Med 50(6):978–981. https://doi.org/10.1007/s00134-024-07438-z - DOI
1. Nadim MK, Kellum JA, Forni L et al (2024) Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting. J Hepatol 81(1):163–183. https://doi.org/10.1016/j.jhep.2024.03.031 - DOI - PubMed - PMC
1. Ma AT, Sole C, Juanola A et al (2024) Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis. J Hepatol 81(3):441–450. https://doi.org/10.1016/j.jhep.2024.03.006 - DOI - PubMed
1. Wong F, Pappas SC, Reddy KR et al (2022) Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure. Aliment Pharmacol Ther 56(8):1284–1293. https://doi.org/10.1111/apt.17195 - DOI - PubMed - PMC

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Springer

[1] Wong F, Pappas SC (2024) Terlipressin use in hepatorenal syndrome - acute kidney injury in cirrhosis. Intens Care Med. https://doi.org/10.1007/s00134-024-07681-4 - DOI

[2] Wong F, Pappas SC (2024) Terlipressin use in hepatorenal syndrome - acute kidney injury in cirrhosis. Intens Care Med. https://doi.org/10.1007/s00134-024-07681-4 - DOI

[3] Nadim MK, Forni LG, Ostermann M (2024) ADQI / ICA Expert Panel. Hepatorenal syndrome in the intensive care unit. Intens Care Med 50(6):978–981. https://doi.org/10.1007/s00134-024-07438-z - DOI

[4] Nadim MK, Forni LG, Ostermann M (2024) ADQI / ICA Expert Panel. Hepatorenal syndrome in the intensive care unit. Intens Care Med 50(6):978–981. https://doi.org/10.1007/s00134-024-07438-z - DOI

[5] Nadim MK, Kellum JA, Forni L et al (2024) Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting. J Hepatol 81(1):163–183. https://doi.org/10.1016/j.jhep.2024.03.031 - DOI - PubMed - PMC

[6] Nadim MK, Kellum JA, Forni L et al (2024) Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting. J Hepatol 81(1):163–183. https://doi.org/10.1016/j.jhep.2024.03.031 - DOI - PubMed - PMC

[7] Ma AT, Sole C, Juanola A et al (2024) Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis. J Hepatol 81(3):441–450. https://doi.org/10.1016/j.jhep.2024.03.006 - DOI - PubMed

[8] Ma AT, Sole C, Juanola A et al (2024) Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis. J Hepatol 81(3):441–450. https://doi.org/10.1016/j.jhep.2024.03.006 - DOI - PubMed

[9] Wong F, Pappas SC, Reddy KR et al (2022) Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure. Aliment Pharmacol Ther 56(8):1284–1293. https://doi.org/10.1111/apt.17195 - DOI - PubMed - PMC

[10] Wong F, Pappas SC, Reddy KR et al (2022) Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure. Aliment Pharmacol Ther 56(8):1284–1293. https://doi.org/10.1111/apt.17195 - DOI - PubMed - PMC

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Terlipressin use in hepatorenal syndrome-acute kidney injury in cirrhosis. Author's reply

Affiliations

Terlipressin use in hepatorenal syndrome-acute kidney injury in cirrhosis. Author's reply

Authors

Affiliations

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources

Similar articles

Cited by

References

Publication types

Related information

LinkOut - more resources

Full Text Sources